3648 results for «2545»
3648 results
Future devices and techniques for structural heart disease
15 Feb 2026 – From PCR Tokyo Valves 2026
This session surveys the future landscape of structural heart disease treatment, addressing current limitations in transcatheter valve technologies and presenting emerging devices and techniques for aortic, mitral, and tricuspid valves. Attendees will gain insights into innovations poised to transform therapeutic options for structural heart disease.
Pulmonary valve: the next frontier in adult structural interventions
19 May 2026 – From EuroPCR 2026
This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Thrombectomy in pulmonary embolism
19 May 2026 – From EuroPCR 2026
This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...
Place of DCB in clinical practice
19 May 2026 – From EuroPCR 2026
This session explores the clinical applications of drug-coated balloons (DCB) across diverse challenging scenarios. It covers management of severely calcified nodules in acute coronary syndrome, healing of intentional dissections in chronic total occlusions using paclitaxel DCB, strategic integration of contemporary technology in complex lesion treatment, and...
The thin line between success and failure in MedTech start ups - Lessons learnt
18 May 2026 – From EuroPCR 2026
This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.
Transcatheter mitral valve replacement - LIVE case
20 May 2026 – From EuroPCR 2026
A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).
A transcatheter mitral...
New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices
20 May 2026 – From EuroPCR 2026
This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...
Strategical approaches to treat patients with multivessel disease
20 May 2026 – From EuroPCR 2026
This comprehensive session focuses on strategic approaches to manage patients with multivessel coronary artery disease. It covers a spectrum of topics including ostial stent implantation techniques, the impact of center volume on CT-guided angiography post-CABG, and physiology-guided PCI versus angiography alone. Insights into percutaneous revascularisation strategies...
Management of stable CAD
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of current management strategies for stable coronary artery disease (CAD). Topics include angiographic predictors influencing PCI efficacy in stable angina, comparative outcomes of immediate versus staged PCI, and analyses of treatment approaches for significant left anterior descending artery disease. The...
Managing complex calcified PCI: pitfalls and complications
20 May 2026 – From EuroPCR 2026
This session addresses the complexities and challenges of performing PCI in heavily calcified coronary lesions. Emphasizing the critical role of imaging in procedural planning, it updates on contemporary tools and techniques to mitigate complications. The session also shares practical experience in managing common complications such as...
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
20 May 2026 – From EuroPCR 2026
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...
Rescue techniques for coronary interventions
20 May 2026 – From EuroPCR 2026
This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...
Back to the future - Lessons from the past that can guide contemporary practice
20 May 2026 – From EuroPCR 2026
Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...
A critical appraisal of the recent evidence in the LAA closure field
20 May 2026 – From EuroPCR 2026
This session critically appraises recent evidence in the left atrial appendage (LAA) closure field, focusing on landmark trials such as CHAMPION-AF and CLOSURE AF. It discusses how these findings may influence patient selection and clinical practice, offering guidance on integrating new evidence into decision-making for stroke...
Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology
20 May 2026 – From EuroPCR 2026
This session invites a re-evaluation of coronary artery disease by shifting focus from ischemia to atheroma, integrating insights from the Lancet Commission for Interventional Cardiology. It explores the significance of plaque burden, biology, and inflammation in guiding PCI decisions and outlines the future role of PCI...
TAVI procedural complications - Part 4: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...
Vascular access: femoral and radial
20 May 2026 – From EuroPCR 2026
This session explores vascular access techniques in interventional cardiology, emphasizing both femoral and radial approaches. It covers access-related bleeding and ischemic complications, safety and efficacy of distal radial programs, and innovations in sheath technology. Additional topics include post-procedural mobilization, management of radial artery recanalization, balloon fenestration...
The value of intravascular imaging in the planning - Optimisation of PCI and dealing with complications
20 May 2026 – From EuroPCR 2026
Highlighting the critical role of intravascular imaging in PCI, this session explores its utility in procedural planning, optimization of outcomes, and identification and management of complications. Through international case studies, it demonstrates how imaging enhances understanding beyond angiography alone and facilitates tailored, effective interventions.
Double face of DCB in clinical practice
20 May 2026 – From EuroPCR 2026
This session examines the dual aspects of drug-coated balloons (DCB) in clinical practice through diverse case studies. Topics include DCB use in left main STEMI, OCT-guided management of in-stent restenosis, expanding indications for complex PCI, and challenges such as DCB failure and decision-making between drug-eluting balloons...